MY142110A - Matrix for sustained, invariant and independent release of active compounds - Google Patents

Matrix for sustained, invariant and independent release of active compounds

Info

Publication number
MY142110A
MY142110A MYPI20043893A MY142110A MY 142110 A MY142110 A MY 142110A MY PI20043893 A MYPI20043893 A MY PI20043893A MY 142110 A MY142110 A MY 142110A
Authority
MY
Malaysia
Prior art keywords
matrix
invariant
sustained
active compounds
independent release
Prior art date
Application number
Inventor
Bianca Bruegmann
Silke Moehlau
Christof Spitzley
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Priority to MYPI20043893 priority Critical patent/MY142110A/en
Publication of MY142110A publication Critical patent/MY142110A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

THE INVENTION CONCERNS A STORAGE STABLE PHARMACEUTICAL FORMULATION COMPRISING PREFERABLY TWO ACTIVE COMPOUNDS IN A NON-SWELLABLE DIFFUSION MATRIX, WHEREBY THE COMPOUNDS ARE RELEASED FROM THE MATRIX IN A SUSTAINED, INVARIANT AND, IF SEVERAL COMPOUNDS ARE PRESENT, INDEPENDENT MANNER AND THE MATRIX IS DETERMINED WITH RESPECT TO ITS SUBSTANTIAL RELEASE CHARACTERISTICS BY ETHYCELLULOSE AND AT LEAST ONE FATTY ALCOHOL. THE INVENTION ALSO CONCERNS METHODS FOR PRODUCING SUCH PHARMACEUTICAL FORMULATIONS.
MYPI20043893 2004-09-23 2004-09-23 Matrix for sustained, invariant and independent release of active compounds MY142110A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20043893 MY142110A (en) 2004-09-23 2004-09-23 Matrix for sustained, invariant and independent release of active compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20043893 MY142110A (en) 2004-09-23 2004-09-23 Matrix for sustained, invariant and independent release of active compounds

Publications (1)

Publication Number Publication Date
MY142110A true MY142110A (en) 2010-09-15

Family

ID=47320705

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20043893 MY142110A (en) 2004-09-23 2004-09-23 Matrix for sustained, invariant and independent release of active compounds

Country Status (1)

Country Link
MY (1) MY142110A (en)

Similar Documents

Publication Publication Date Title
TW200716113A (en) Matrix for sustained, invariant and independent release of active compounds
EE05256B1 (en) A pharmaceutical formulation wherein the active ingredient is uniformly dispersed in the excipient masterbatch and the dosage form comprising it.
UA74339C2 (en) Dosage form of proton pump inhibitor representing individual matrix-included units and method for its manufacture
CR10032A (en) SOLID PREPARATION
AR099437A2 (en) MATRIX FOR SUSTAINED, INVARIABLE AND INDEPENDENT RELEASE OF ACTIVE COMPOUNDS
WO2007128923A3 (en) Method for the preparation of a biocompatible gel with controlled release of one or more active ingredients with low solubility in water, gels thus obtained and their use
AR069552A1 (en) FORMULATIONS FOR THE TREATMENT OF SEEDS AND METHODS OF USE
SV2004001556A (en) ACID PREPARATIONS OF INSULIN WITH IMPROVED STABILITY
AU2002221939A1 (en) Rapidly disintegrating tablet comprising an acid-labile active ingredient
WO2008052033A3 (en) Ibuprofen composition
UA99645C2 (en) Anti-inflammatory and antiallergic gel
MY138975A (en) Novel preparation and administration form comprising an acid-labile active compound
MY142110A (en) Matrix for sustained, invariant and independent release of active compounds
ATE400256T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A CATIONIC EXCIPIENT
NO20055601L (en) Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
PL378106A1 (en) Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method
AR040764A1 (en) PHARMACEUTICAL FORMULATIONS OF EPINASTINE, PSEUDOEFEDRINE AND METHYLFEDRINE
AR048432A1 (en) DIURETIC COMPOSITIONS OF PROLONGED RELEASE
WO2004073592A3 (en) Semi-solid immediate-release oral formulations comprising an anticancer hydrophobic agent, a polyglycolised glyceride and a hydrophilic carrier
AR028699A1 (en) NEW FORMULATION
ATE296606T1 (en) RAPID RELEASE PHARMACEUTICAL PHARMACEUTICAL PHARMACEUTICAL FORM CONTAINING POLYMORPHOUS TIBOLONE
ECSP034501A (en) TABLETS CONTAINING EPINASTINE MANUFACTURED BY DIRECT COMPRESSION
苏曼 Jack’s Schedule
BG108898U (en) Medicamentous form of pyracetam